| Ackerman, Yossi (former President + CEO of Elbit Systems) |
n. a. |
Elbit Systems Ltd. (TASE + Nasdaq: ESLT) |
|
| Agmoni, Eyal (Chartered Group 201910 Chairman) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Chartered Group |
|
| Aguiar, Sebastian (Samsara Therapeutics 201902 COO + Founder) |
Chief Operating Officer (COO) |
|
|
| Akkermans, Michel |
n. a. |
|
|
| Allen, Mark (Elevian 202209 CEO) |
Chief Executive Officer (CEO) |
Elevian |
|
| Almagro, Juan Carlos (GlobalBio 202310 CEO + Founder) |
Chief Executive Officer (CEO) |
|
|
| Amati, Luigi (Meta Group 201509 Investment Manager at Meta Ingenium) |
Investment Manager |
Meta Group (Group) |
|
| Anderson (formerly Broder), Elizabeth (LianBio 202103 VP Communications + IR before MeiraGTx) |
Public Relations Manager / Investor Relations Manager |
LianBio |
|
| Anglade, Eddy (Tenpoint Therapeutics 202307 CEO) |
n. a. |
|
|
| Antoine, Lysta N. (Global Food Safety Partnership 201709 CEO) |
Chief Executive Officer (CEO) |
Global Food Safety Partnership (GFSP) |
|
| Antonelli, Pierluigi (Angelini 202103 CEO of Angelini Pharma) |
Chief Executive Officer (CEO) |
Angelini (Group) |
|
| Arkin, Mori (Arkin Holdings) |
n. a. |
|
|
| Astrom, Kalle (Finnvera 201306 Investment Manager) |
Investment Manager |
Finland (govt) |
|
| Bailey, James (Bail Capital 202012) |
n. a. |
Bail Capital |
|
| Ballal, Rahul (Mediar Therapeutics 202303 CEO before Imara) |
Chief Executive Officer (CEO) |
|
|
| Balthrop, Patrick J. (Apalachee Ventures 201602 Founding Prinicpal before Luminex 200405–2014 CEO) |
Principal (venture capital) |
Apalachee Ventures |
|
| Barookhian, Natanel (TechU Ventures 202403 Managing Partner) |
Managing Partner (investment firm) |
TechU Ventures |
|
| Barsan, Valentin (Vali) (SoftBank 202201 at SoftBank Investment Adivsers) |
Investment Manager |
SoftBank (Group) |
|
| Barzi, Roberto (VitaTech SA 201902 Director) |
Investment Manager |
VitaTech S.A. (Zambon Family + other European high-net-worth private investors) |
|
| Bastid, Pierre |
n. a. |
|
|
| Belldegrun, Ben (Pontifax AgTech 202006 Managing Partner) |
Managing Partner |
Pontifax (Group) |
|
| Benaich, Nathan (Air Street Capital 202103 General Partner) |
General Partner (venture partner) |
Air Street Capital (Nathan Benaich) |
|
| Benjumea Llorente, Javier (Abengoa 201503 Managing Director) |
President/Director/Head Business Group/Unit/Division |
|
|
| Bernardo, Joseph E. (Joe) (Linden Capital 201908 Operating Partner + BCG Senior Advisor before Thermo Fisher + Siemens) |
Partner (venture partner) |
Linden Capital Partners |
|
| Berthier, Anne-Lise (Freelance writer for BioPharmanalyses before Reed Elsevier) |
Journalist |
|
|
| Biesmans, Steven (UCB 202311 Principal at UCB Ventures) |
Principal (venture capital) |
UCB (Group) |
|
| Bing, Chen (AstraZeneca 202211 Managing Director of AZ-CICC Healthcare Investment Fund) |
Managing Director |
AstraZeneca (Group) |
|
| Bissay, Philippe (H.A.C. Pharma 202211 CEO) |
Chief Executive Officer (CEO) |
H.A.C. Pharma (FR) |
|
| Bissinger, Matthias (Business Angel 202203) |
n. a. |
|
|
| Bode, Tim (Business Angel) |
n. a. |
PERSON |
|
| Boël, Harold (Sofina 202109 CEO) |
Chief Executive Officer (CEO) |
|
|
| Boerman, Manja (Catalent 202102 President of Catalent Cell & Gene Therapy) |
President/Director/Head Business Group/Unit/Division |
Catalent (Group) |
|
| Bogaert, Cedric (myNEO 202205 CEO + Co-Founder) |
Chief Operating Officer (COO) |
|
|
| Boman, Sakari (Vital Scientific 200607) |
n. a. |
Elitech (Group) |
|
| Bonislawski, Adam |
Editor / Publisher |
|
|
| Bottomley, Josh (LexisNexis 200802 Managing Director) |
Managing Director |
Reed Elsevier (Group) |
|
| Boury, Guillaume (Telos Impact 202309 Investment Manager) |
Investment Manager |
Telos Impact |
|
| Brandenburg, Mario (Member of German Parliament + Technology Policy Spokesman of FDP) |
n. a. |
|
|
| Brennecke, Marcus (EQT Partners 201706 Partner + Investment Advisor to EQT VII fund) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
|
| Breski, Yaron (RM Global Partners 201902 Managing Director) |
Managing Director |
RM Global Partners (RMGP) |
|
| Breugelmans, Matthias (Elastrin 202209 CEO) |
Chief Executive Officer (CEO) |
Elastrin Therapeutics |
|
| Brun, Pascal (H&M 202205 Head of Sustainability) |
n. a. |
|
|
| Brüggen, Jochen |
n. a. |
PERSON |
|
| Buchris, Yodfat (Blumberg Capital 202205 Managing Director) |
Managing Director |
Blumberg Capital |
|
| Burkiewicz, Adam (A&A Biotechnology 1993– President + founder) |
President/Director/Head Business Group/Unit/Division |
|
|
| Calikowski, Tomasz (EU 201403 Scientific Officer of European Commission) |
Administrative Officer (personnel) |
|
|
| Carninci, Piero (Human Technopole + Riken Center for Integrative Medical Sciences + Co-Founder Transine Therapeutics) |
Researcher (university / research institute) |
|
|
| Carreel, Eric (Indigo) |
n. a. |
Indigo (holding company of Eric Carreel) |
|
| Cassak, David (Innovation in Medtech LLC 2014 Managing Partner + Co-Founder before Informa IN VIVO) |
Managing Partner |
Innovation in Medtech LLC |
|
| Cassel, Fredrik (Creandum 202308 General Partner) |
General Partner (venture partner) |
Creandum |
|
| Cho, Jeong-Woo (SK Group 201902 CEO of SK Biopharmaceuticals) |
Chief Executive Officer (CEO) |
SK Group (Group) |
|
| Choveaux, David (Sparta Biodiscovery 202309 Business Development + Operations) |
Business Development Manager / Strategy Manager |
Sparta Biodiscovery Ltd. |
|
| Chusseau, Maylis (Aquitaine Science Trasfert 201905 President) |
technology transfer |
|
|
| Clemens, Ralf (CureVac 201603 SAB + Supervisory Board Member before GSK Biologicals + Novartis) |
scientific advisory board (SAB) |
|
|
| Coessens, Bert (myNEO 202205 formerly founder + COO of Cartagenia) |
Chief Operating Officer (COO) |
|
|
| Coleman, Michael (InGeneron 201005 Managing Director) |
n. a. |
|
|
| Collan, Robert (FRIBA Investment 202106 Managing Director) |
Managing Director |
FRIBA Investment |
|
| Colsman, Wolfgang (Zontal 202305 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
|
| Connelly, Robert T. (Elicio Therapeutics 201903– CEO before Pronutria + Pulmatrix + Diversys/Domantis + IGEN Intl) |
Chief Executive Officer (CEO) |
|
|
| Cook, Kathryn (NuCicer 202211 CEO + Co-Founder) |
n. a. |
|
|
| Coucke, Marc (Alychlo before Omega Pharma 1987– CEO + Founder) |
Chief Executive Officer (CEO) |
Alychlo (family office of Marc Coucke) |
|
| Crawford-Brunt, Andre (Braavos Investment Advisors 202102 General Partner) |
Board member, non-executive |
Braavos Investment Advisers |
|
| Curtius, John (Tiger Global Management 202109 Partner) |
Partner (venture partner) |
Tiger Global Management, LLC |
|
| Dabagov, Anatoly (Meditsinskie technologii Ltd 201009 President) |
President/Director/Head Business Group/Unit/Division |
|
|
| Dawkins, Keith D. (Shockwave 2019– CMO before Boston Scientific) |
Board member, non-executive |
|
|
| Dawson, Mike (Cantab Anti-Infectives + Novacta Biosystems before GSK) |
n. a. |
|
|
| Deigin, Yuri (Youth Bio 202209 CEO) |
Chief Executive Officer (CEO) |
Youth Bio |
|
| Denis, Pierre (202206 former CEO of Jimmy Choo) |
n. a. |
|
|
| Desmond, Dermot |
n. a. |
|
|
| Dhar, Rakhshita (Bayer 202206 Senior Director of Venture Investments Health at Leaps by Bayer) |
Investment Manager |
Bayer (Group) |
|
| Dixit, Rakesh (Bionavigen 202110 CEO + Regio Biosciences 202110 CSO before Merck & Co + JnJ + Medimmune + AZ) |
n. a. |
|
|
| Dodds-Smith, Ian (Arnold & Porter 201910 Co-Head Food, Drug + Medical Device practice in Europe) |
Attorney / Lawyer |
Arnold & Porter LLP |
|
| Dombrosky, John (Bayer 201910– CEO of Oerth Bio) |
Chief Executive Officer (CEO) |
Bayer (Group) |
|
| Drion, Pierre |
n. a. |
|
|
| Ducrocq, Geoffrey (HTP Europe 202112 Director) |
President/Director/Head Business Group/Unit/Division |
|
|
| Duerr, Ann (HIV Vaccine Trials Network 200601) |
n. a. |
HIV Vaccine Trials Network (HVTN) |
|
| Duggan, Mark (AstraZeneca 201307 VP Neuroscience iMed) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
|
| Dyson, Esther |
n. a. |
|
|
| Earl, Michael (Celtic Pharma 201301 + Pro Bono Bio 201209 COO) |
Partner (venture partner) |
Auven Therapeutics (Group) |
|
| Ebbecke, Dirk (Körber 202310 Head of Product Marketing at Körber Pharma) |
Sales Manager / Marketing Manager |
|
|
| Ebert, Eric (Wando Founder) |
n. a. |
|
|
| Ebitsch, Susanne (Univ Leipzig 202210 CEO of b-ACT matter) |
Chief Executive Officer (CEO) |
University of Leipzig |
|
| Eckhardt, Jürgen (Bayer 201904 Head of Leaps by Bayer) |
Investment Manager |
Bayer (Group) |
|
| Edick, Paul R. (3G Advisors 201603 Founding Partner) |
Company Founder |
|
|
| Ehle, Dirk (Bayer 201308 Global Head of Bayer HealthCare Animal Health Division) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
|
| Elff, Manfred (Niedersächsisches Zentrum für Biomedizintechnik und Implantatforschung 201009 Managing Director) |
Managing Director |
Niedersächsisches Zentrum für Biomedizintechnik und Implantatforschung (NZ-BMT) |
|
| Ellenbogen, Henry (Durable Capital 202106 Managing Partner + Chief Investment Officer) |
Managing Partner (investment firm) |
Durable Capital Partners LP |
|
| Elliott, Eric (Voluntis 202011 Board Chairman) |
n. a. |
|
|
| Faeh, Urban (Bruker 201001– President Bruker Optics division joined Bruker 1998 as sales manager) |
President/Director/Head Business Group/Unit/Division |
Bruker BioSciences (Group) |
|
| Farmer, Edward (202312 PR Consultant) |
Public Relations Manager / Investor Relations Manager |
OTHER |
|
| Fatscher, Hans Peter (Qiagen 201710– VP + Head of Qiagen Custom Solutions business) |
President/Director/Head Business Group/Unit/Division |
Qiagen Custom Solutions (business unit) |
|
| Fickel, James (Starbloom Capital 202201) |
Investment Manager |
Starbloom Capital (crypto-based family office) |
|
| Fiorentino, Ed (TerSera Therapeutics 201602– CEO before 22y veteran at Abbott) |
Chief Executive Officer (CEO) |
|
|
| Fiorina, Paolo (Univ Milan + HSR + Harvard Medical School) |
Professor |
University of Milan |
|
| Fischer, Hartmut (A&M Labor 201201 Managing Director) |
Managing Director |
A&M Labor für Analytik und Metabolismusforschung Service Gmb |
|
| Forest, Eric (Euronext 201404 CEO at EnterNext) |
Chief Executive Officer (CEO) |
Euronext (Group) |
|
| Fratacci, Thomas (SPRIM Global Investments 202302 CFO) |
n. a. |
|
|
| Fritz, Jutta (NanoSphere Biotechnologies 202207 CBO before Blackfield + Kinaxo+ Max Planck Innovation) |
Business Development Manager / Strategy Manager |
|
|
| Fry, Nigel (Schauenburg 202309– CEO of Schauenburg Analytics Group before Antylia Scientific + GE Healthcare) |
Chief Executive Officer (CEO) |
Schauenburg (Group) |
|
| Fürstner, Alois (Max Planck 1993– MPI for Coal Research Mühlheim) |
Professor |
Max Planck Society for the Advancement of Science |
|
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
